Tenet Healthcare Co. (NYSE:THC - Free Report) - Equities research analysts at Leerink Partnrs dropped their Q1 2025 earnings per share estimates for Tenet Healthcare in a research report issued on Thursday, April 24th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $2.99 per share for the quarter, down from their prior forecast of $3.07. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's Q1 2026 earnings at $3.36 EPS, Q2 2026 earnings at $3.31 EPS, Q3 2026 earnings at $3.13 EPS and Q4 2026 earnings at $3.85 EPS.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%.
A number of other brokerages have also weighed in on THC. Baird R W lowered Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Guggenheim initiated coverage on Tenet Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $165.00 target price on the stock. Truist Financial lowered their target price on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Robert W. Baird reaffirmed a "neutral" rating and set a $137.00 target price (down from $153.00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Finally, Morgan Stanley began coverage on Tenet Healthcare in a research report on Wednesday, March 26th. They set an "overweight" rating and a $165.00 target price on the stock. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $165.44.
Get Our Latest Report on THC
Tenet Healthcare Trading Up 1.4 %
THC traded up $1.72 during trading on Friday, hitting $123.82. The company's stock had a trading volume of 1,912,250 shares, compared to its average volume of 1,518,931. Tenet Healthcare has a twelve month low of $96.14 and a twelve month high of $171.20. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The stock's fifty day moving average price is $126.50 and its 200-day moving average price is $136.79. The firm has a market capitalization of $11.69 billion, a P/E ratio of 3.84, a PEG ratio of 1.02 and a beta of 1.77.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its position in shares of Tenet Healthcare by 3.5% in the fourth quarter. Geode Capital Management LLC now owns 2,116,121 shares of the company's stock valued at $268,591,000 after purchasing an additional 71,454 shares in the last quarter. Norges Bank bought a new stake in shares of Tenet Healthcare during the fourth quarter valued at about $190,819,000. Dimensional Fund Advisors LP lifted its holdings in shares of Tenet Healthcare by 22.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,493,532 shares of the company's stock worth $188,524,000 after buying an additional 272,906 shares in the last quarter. AQR Capital Management LLC grew its stake in Tenet Healthcare by 20.8% during the fourth quarter. AQR Capital Management LLC now owns 872,117 shares of the company's stock valued at $110,087,000 after acquiring an additional 150,361 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in Tenet Healthcare by 22.0% in the 4th quarter. Northern Trust Corp now owns 848,049 shares of the company's stock worth $107,049,000 after purchasing an additional 152,671 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Tenet Healthcare
In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares in the company, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.81% of the stock is owned by corporate insiders.
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Stories
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
